Search

Your search keyword '"Balabanova, Yanina"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Balabanova, Yanina" Remove constraint Author: "Balabanova, Yanina"
225 results on '"Balabanova, Yanina"'

Search Results

1. Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study

7. Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe

8. A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians

10. Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis.

11. Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countries

12. Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries

14. Utility of propidium monoazide viability assay as a biomarker for a tuberculosis disease

18. Risk of venous thromboembolism in men with prostate cancer compared with men in the general population : a nationwide population-based cohort study in Sweden

19. Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom

22. Additional file 1 of Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

28. Rates of latent tuberculosis in health care staff in Russia

29. Rationale and design of a European epidemiological post-authorization safety study (PASS) program : rivaroxaban use in routine clinical practice

30. Differentiation of tuberculosis strains in a population with mainly Beijing-family strains

33. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia

34. Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the Beijing strain family. (Research)

36. Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice

38. Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countries

39. Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK

40. Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK

41. Analysis of undiagnosed tuberculosis-related deaths identified at post-mortem among HIV-infected patients in Russia: a descriptive study

43. Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke.

44. Tuberculosis cases caused by heterogeneous infection in Eastern Europe and their influence on outcomes

47. Beijing clades of Mycobacterium tuberculosis are associated with differential survival in HIV-negative Russian patients

48. Beijing clades of Mycobacterium tuberculosis are associated with differential survival in HIV-negative Russian patients

49. Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration

50. Evolution and transmission of drug-resistant tuberculosis in a Russian population

Catalog

Books, media, physical & digital resources